
{
  "documentMetadata": {
    "title": "Tuberculosis, Pulmonary",
    "sourceFile": "syndromes/infectious_syndromes/Tuberculosis, Pulmonary.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Pulmonary Tuberculosis"
    },
    {
      "type": "paragraph",
      "text": "Pulmonary tuberculosis (TB) is a contagious bacterial infection that primarily affects the lungs but can spread to other parts of the body. It is caused by the bacterium Mycobacterium tuberculosis."
    },
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Manifestations"
    },
    {
      "type": "list",
      "items": [
        "Persistent cough lasting more than 3 weeks, often with sputum production (may be bloody)",
        "Fever, chills, night sweats",
        "Unexplained weight loss, fatigue, malaise",
        "Chest pain"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Treatment of Drug-Susceptible Pulmonary TB"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 3,
          "text": "Initial Phase (Intensive Phase)"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "appliesTo": {
              "description": "All patients with new-onset pulmonary TB"
            },
            "components": [
              { "drug": "Isoniazid", "route": "PO", "frequency": "Daily" },
              { "drug": "Rifampin", "route": "PO", "frequency": "Daily", "connector": "+" },
              { "drug": "Pyrazinamide", "route": "PO", "frequency": "Daily", "connector": "+" },
              { "drug": "Ethambutol", "route": "PO", "frequency": "Daily", "connector": "+" }
            ],
            "durationDetail": {
              "fixedDuration": "2 months"
            },
            "notes": "Standard four-drug regimen (RIPE). Ethambutol can be discontinued if drug susceptibility testing shows sensitivity to isoniazid and rifampin."
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 3,
          "text": "Continuation Phase"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "components": [
              { "drug": "Isoniazid", "route": "PO", "frequency": "Daily" },
              { "drug": "Rifampin", "route": "PO", "frequency": "Daily", "connector": "+" }
            ],
            "durationDetail": {
              "fixedDuration": "4 months"
            },
            "notes": "The continuation phase is extended to 7 months (for a total of 9 months of therapy) in patients with cavitary pulmonary disease whose sputum culture at 2 months is positive."
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Diagnosis"
    },
    {
      "type": "diagnosticTest",
      "diagnosticTestData": {
        "name": "Sputum Smear and Culture",
        "analyte": "Mycobacterium tuberculosis",
        "sampleType": "Sputum",
        "strengthOfRecommendation": "Recommended",
        "notes": "At least 3 sputum specimens should be collected for acid-fast bacilli (AFB) smear and mycobacterial culture. Culture is the gold standard."
      }
    },
    {
      "type": "diagnosticTest",
      "diagnosticTestData": {
        "name": "Nucleic Acid Amplification Test (NAAT)",
        "sampleType": "Sputum",
        "notes": "Recommended for at least one sputum specimen. Provides rapid identification of M. tuberculosis."
      }
    },
    {
      "type": "diagnosticTest",
      "diagnosticTestData": {
        "name": "Chest X-ray",
        "interpretation": "Typical findings include upper lobe infiltrates, cavitation, and hilar adenopathy. However, findings can be variable."
      }
    }
  ]
}
